The Operation Dilemmas, Cause Analysis and Institutional Improvement of the Market Exclusivity Period System for First Generic Drugs in China
1.Civil, Commercial and Economic Law School, China University of Political Science and Law, Beijing 100088
2.BrightGene Bio-Medical Technology Co., Ltd., Suzhou 215123
3.School of Pharmacutical Sciences, Wuhan University, Wuhan 430071
4.School of Chemical Engineering and Pharmacy, Wuhan Institute of Technology, Wuhan 430205
5.School of Law, Humanities and Society, Wuhan University of Technology, Wuhan 430070
6.Law and Business School of Wuhan Instiute of Technology (School of Intellectual Property), Wuhan 430205
7.Coherent Biopharma (suzhou) Co., Ltd., Suzhou 215123
收起